Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mika Kamata-Sakurai
An Anti–glypican 3/Cd3 Bispecific T Cell–redirecting Antibody for Treatment of Solid Tumors
Science Translational Medicine
Medicine
Related publications
A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
A Novel Bispecific Single-Chain Antibody for ADAM17 and CD3 Induces T-Cell-Mediated Lysis of Prostate Cancer Cells
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
A Novel GUCY2C-CD3 T Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers
Clinical Cancer Research
Cancer Research
Oncology
Initial Experience With the Bispecific Anti-Cea Anti-Cd3 Antibody and Its Expected Impact on Future Treatment for Patients With Colorectal Cancer
ESMO Open
Cancer Research
Oncology
Efficient Elimination of Chronic Lymphocytic Leukaemia B Cells by Autologous T Cells With a Bispecific Anti-Cd19/Anti-Cd3 Single-Chain Antibody Construct
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Phase I Study of Anti-Cd3 X Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer Patients
Prostate Cancer
Cancer Research
Oncology
Urology
A Novel Asymmetrical Anti-Her2/Cd3 Bispecific Antibody Exhibits Potent Cytotoxicity for HER2-positive Tumor Cells
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
CAR T-Cell Therapy for Solid Tumors?
Cancer Discovery
Oncology
Adoptive T-Cell Therapy for Solid Tumors
American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
Medicine
